Jorge Luis Granadillo De Luque

Medicine & Life Sciences

1. Phenotype 100%
2. Neurodevelopmental Disorders 92%
3. Whole Exome Sequencing 90%
4. Monosomy 2q24 Chromosome 2 88%
5. Muscle Hypotonia 87%
6. Epigenomics 83%
7. Neurologic Manifestations 79%
8. Autistic Disorder 78%
9. DNA Methylation 78%
10. Intellectual Disability 74%
11. Timothy syndrome 74%
12. Microcephaly 73%
13. Inborn Genetic Diseases 73%
14. Molybdenum cofactor deficiency 73%
15. Epilepsy 66%
16. CHARGE Syndrome 63%
17. ATP Binding Cassette Transporter, Subfamily B, Member 11 63%
18. Genes 62%
19. Whole Genome Sequencing 61%
20. Mucolipidoses 59%
21. Genome 59%
22. Fused Kidney 57%
23. Medicine 57%
24. Intrahepatic Cholestasis 56%
25. Medical Genetics 53%
26. HMGB1 Protein 52%
27. Spermidine 51%
28. Long QT Syndrome 51%
29. Secondary Hyperparathyroidism 48%
30. Protein Tyrosine Phosphatases 48%
31. Wilms Tumor 47%
32. Drug Resistant Epilepsy 45%
33. Cholestasis 44%
34. DNA-Binding Proteins 44%
35. molybdenum cofactor 43%
36. Glycosaminoglycans 42%
37. Proline 42%
38. Seizures 41%
39. Exome 40%
40. Attention Deficit Disorder with Hyperactivity 40%
41. Premature Infants 38%
42. Growth 37%
43. Names 37%
44. UDP-N-acetylglucosamine-lysosomal-enzyme-N-acetylglucosaminephosphotransferase 37%
45. Gingival Hypertrophy 34%
46. Ataxia 34%
47. Neurodegenerative Diseases 34%
48. Progressive familial intrahepatic 1 Cholestasis 32%
49. Haploinsufficiency 32%
50. Heart Diseases 32%